Jose Romelito Villacarlos Causin, AGNP-C

Jose Romelito Causin practices at Kaiser Permanente Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente.

Jose Romelito Causin's NPI, 1811418577, was assigned on July 3, 2017. Jose Romelito Causin holds California license 95005768.

Jose Romelito Causin's primary practice is Kaiser Permanente Los Angeles Medical Center, at 4867 Sunset Blvd, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (323) 783-4011.

Jose Romelito Causin's primary practice is Kaiser Permanente Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente. Jose Romelito Causin is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Southern California Permanente Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Jose Romelito Causin practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Jose Romelito Causin's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Jose Romelito Causin is licensed in California.

Dmand AI lists insomnia and UTI among the conditions Jose Romelito Causin treats.

CMS data shows 136 Medicare services from Jose Romelito Causin across 1 procedure code in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $9,210 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Jose Romelito Causin in 2024. The largest group is 65 to 74, with 19 patients. 74% of them have high blood pressure, and 72% have high cholesterol. 41% are also on Medicaid. Their average risk score is 4.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jose Romelito Causin's median patient age at 59, with 64% women.

In 2024, Jose Romelito Causin wrote 267 Medicare Part D claims for 59 patients. 78% of them were for generic drugs. CMS names the drug for 147 of them, across 8 drugs with 11 or more claims each, at $276,337 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Jose Romelito Causin for performance year 2024, reported as part of a group.

CMS Open Payments shows 1 general payment to Jose Romelito Causin from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $123.